<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"carcinoma":2,
"lymph node excision/methods":1,
"papillary/surgery":1,
"thyroid neoplasms/surgery":1,
"treatment outcome":1,
"diagnosis":3,
"thyroid malignancy":1,
"thyroid nodule":2,
"thyroid-stimulating hormone (TSH)":1,
"ultrasound":3,
"clinical decision-making modules (CDMMs)":1,
"persistent thyroid cancer":1,
"recurrent thyroid cancer":1,
"reoperation":1,
"thyroid cancer care collaborative (TCCC)":1,
"cystic lesions":1,
"liquid-based cytology":1,
"non-functioning lesions":1,
"parathyroid lesions":1,
"Anaplastic thyroid carcinoma":2,
"Hodgkin's lymphoma":1,
"Horner's syndrome":1,
"Recurrent laryngeal nerve palsy":2,
"Sarcoma":1,
"Thyroid neoplasm":1,
"Incidentaloma":1,
"Nuclear imaging":1,
"PET CT":1,
"Thyroid":12,
"UK-453061":1,
"kidney":1,
"lersivirine":1,
"liver":1,
"neoplasia":2,
"rat":1,
"IMRT":1,
"head and neck cancer":2,
"larynx cancer":1,
"proton therapy":1,
"radiotherapy":2,
"biomarkers":1,
"diagnostic panel":1,
"machine learning":1,
"prediction model":1,
"thyroid cancer":14,
"SIST score":1,
"TGDC score":1,
"Thyroglossal duct cyst":2,
"dermoid cyst":1,
"neck mass":1,
"pediatric":1,
"ultrasonography":2,
"Breast cancer":5,
"Immediate reconstruction":1,
"Neoadjuvant chemotherapy":2,
"Perforator flap":1,
"I-131 ablation":1,
"effective half-life":1,
"recombinant human thyroid-stimulating hormone":1,
"thyroid hormone withdrawal":2,
"T helper type 1 response":1,
"Toll-like receptor":1,
"cancer immunotherapy":1,
"imiquimod":1,
"indoleamine 2,3-dioxygenase":1,
"Calcified lymph nodes,":1,
"Chain of rings,":1,
"Metastases":1,
"Thyroid cancer,":1,
"breast":1,
"fine-needle aspiration cytology":2,
"metastatic medullary thyroid carcinoma":1,
"cytology":4,
"fine-needle aspiration":3,
"oncocytic neuroendocrine carcinoma":1,
"thymus":1,
"Differential diagnosis,":1,
"Immunohistochemistry":3,
"Plasmocytoma,":1,
"Thyroid,":1,
"Breast cancer patient":1,
"Meta-analysis":3,
"Randomized controlled trial":1,
"Traditional Chinese medicine":1,
"circadian clock":1,
"follicular thyroid malignancies":1,
"hypothalamic-pituitary-thyroid axis":1,
"thyroid gland":2,
"thyroid hormones":1,
"AgNORs":1,
"follicular lesions":1,
"Surveillance, Epidemiology, and End Results Program":1,
"cancer-specific survival":1,
"mortality":3,
"prognostic factor":1,
"Differentiated thyroid cancer":2,
"Thyroglobulin":1,
"Angiogenesis inhibitors":1,
"Elevated serum cholesterol":1,
"Elevated serum triglycerides":1,
"Hypercholesterolemia":1,
"Hypertriglyceridemia":1,
"Kidney cancer":1,
"Thyroid function test":1,
"mRCC":1,
"Anaplastic":1,
"Follicular":1,
"Medullary":1,
"Papillary":1,
"Pathway":1,
"Radioiodine therapy":1,
"Targeted therapy":2,
"Thyroid carcinoma":4,
"Agenda":1,
"Cancer burden":1,
"Delphi technique":1,
"Early detection of cancer":2,
"Helicobacter pylori":1,
"Hospices":1,
"Priority":1,
"Research plan":1,
"Thyroid neoplasms":4,
"Management":2,
"struma ovarii":3,
"Biobank resource center":1,
"Frozen section":1,
"Molecular biology":2,
"Surgery":1,
"2-D electrophoresis":1,
"Cathepsin D":1,
"Heat shock protein 27":1,
"TRIP6":1,
"Taxane resistance":1,
"Iodine-refractory":2,
"Sorafenib":2,
"Sunitinib":1,
"Systemic therapy":1,
"VEGF":1,
"anxiety":1,
"depression":1,
"oncology":1,
"psychosocial distress":1,
"BRAF":2,
"Diffuse sclerosing variant":1,
"Papillary carcinoma":4,
"Review":4,
"outcomes":1,
"race":1,
"survival":3,
"Graves’ disease":2,
"Hyperthyroidism":2,
"Hypocalcemia":1,
"Thyroidectomy":3,
"Toxic multinodular goiter":1,
"BRAFV600E mutation":1,
"papillary thyroid microcarcinoma":1,
"prognosis":3,
"Positron emission tomography":1,
"Somatostatin receptor":1,
"Theranostic":1,
"Tumor heterogeneity":2,
"molecular genetics":1,
"neuroendocrinology":1,
"(18)F-fluorodeoxyglucose positron emission tomography":1,
"Anaplastic thyroid cancer":2,
"CD56 antigen":1,
"HBME-1 antigen":1,
"Thyroid tumors of uncertain malignant potential":1,
"CD74":1,
"antibody":1,
"macrophage migration inhibitory factor":1,
"connector enhancer of KSR (CNKSR)":1,
"kinase suppressor of RAS (KSR)":1,
"notch signaling":1,
"oxidative phosphorylation":1,
"Elastography":1,
"Malignancy":1,
"Advanced differentiated thyroid cancer":1,
"Axitinib":1,
"PIK3CA":1,
"RAS":1,
"VEGFR":1,
"indeterminate":1,
"resection":1,
"risk of malignancy":1,
"Blue dye":1,
"Sentinel lymph node biopsy":1,
"thyroid cancer treatment":1,
"tyrosine kinase inhibitor":1,
"BCR-Abl":1,
"Bosutinib (PubMed CID: 5328940)":1,
"Catalytic spine":1,
"Dasatinib (PubMed CID: 3062316)":1,
"Ponatinib (PubMed CID: 24826799)":1,
"Regulatory spine":1,
"SH2 domain":1,
"SH3 domain":1,
"Saracatinib (PubMed CID: 10302451)":1,
"Targeted cancer therapy":1,
"Vandetanib (PubMed CID: 3062316)":1,
"RNA-Seq":1,
"clonal evolution":1,
"thyroid tumors":1,
"SDHx":1,
"gene expression":1,
"papillary thyroid cancer":2,
"variant":1,
"Anti-tumor":1,
"Diosbulbin B":1,
"Hepatotoxicity":1,
"Inflammation":2,
"Oxidative stress injury":1,
"Scutellarin":1,
"Hepatic metabolism":1,
"Human relevance framework":1,
"Liver enzyme induction":1,
"Mode of action":1,
"Pronamide":1,
"Thyroid follicular cell adenomas":1,
"Uridine diphosphate glucuronosyltransferase":1,
"Weight of evidence":1,
"(131)I":1,
"Carcinome papillaire de la thyroïde":1,
"Continuous ambulatory peritoneal dialysis therapy":1,
"Dialyse péritonéale continue ambulatoire":1,
"Hemodialysis":1,
"Hémodialysé":1,
"Iodine-131":1,
"Papillary thyroid carcinoma":3,
"Radiation safety":1,
"Radioprotection":1,
"Māori":1,
"New Zealand":1,
"avoidable mortality":1,
"cancer":2,
"relative survival":1,
"Organ Preservation":1,
"carbon dioxide laser":1,
"Antígeno carcinoembrionario":1,
"Cabozantinib":1,
"Calcitonin":2,
"Calcitonina":1,
"Carcinoembryonic antigen":1,
"Carcinoma medular de tiroides":1,
"Consenso de expertos":1,
"Cáncer de tiroides":1,
"Expert consensus":1,
"Guidelines":1,
"Guía":1,
"Medullary thyroid carcinoma":1,
"Vandetanib":1,
"RET gene":1,
"in silico analysis":1,
"medullary thyroid cancer":1,
"multiple endocrine neoplasia":1,
"Decision support techniques":1,
"Neoplasms":5,
"Risk":1,
"Secondary prevention":1,
"Survivors":1,
"Carcinoma diferenciado de tiroides":1,
"Differentiated thyroid carcinoma":2,
"Sistemas de estadificación":1,
"Staging systems":1,
"Incidence":2,
"Korea":2,
"Prevalence":1,
"(131)I-whole body scan":1,
"rhTSH":1,
"2015":1,
"Forecasting":1,
"BRAF mutation":2,
"Cell transfer":1,
"Molecular":1,
"extracellular matrix metalloproteinase inducer/human epidermal growth factor receptor-2":1,
"immunofluorescence":1,
"lymph node metastasis":2,
"CA 125":1,
"ascites":1,
"mature teratoma":1,
"pleural effusion":1,
"pseudo-Meigs’ syndrome":1,
"head and neck ultrasound":2,
"sonography":2,
"subacute thyroiditis":1,
"Hashimoto thyroiditis":1,
"bone":1,
"calcium":1,
"parathyroid hormone":1,
"vitamin D":1,
"hypothyroidism":2,
"late radiation toxicity":1,
"radiation therapy":1,
"Amino acids":1,
"Hydrophilic interaction chromatography":1,
"Mobile phase additive":1,
"Multiple reaction monitoring":1,
"Phthalic acid":1,
"FDG":1,
"Outcome":1,
"PET/CT":1,
"Ablation":1,
"thyroglossal duct remnant":1,
"Axillary nodal metastasis":1,
"Iodine-131 single-photon emission tomography/computed tomography":1,
"surgical excision":2,
"Iodine-131 single-photon emission computed tomography/computed tomography":1,
"mediastinal ectopic benign goiter":1,
"Lymphocytes":1,
"Neutrophils":1,
"DNA damage":1,
"NADPH oxidase":1,
"ionizing radiation":1,
"oxidative stress":1,
"genetics":1,
"next-generation sequencing":1,
"poorly differentiated thyroid carcinoma":1,
"Thyroid carcinomas":1,
"diagnostic biomarkers":1,
"microRNA":1,
"prognosis prediction":1,
"risk assessment":1,
"HIF1α inhibitor":1,
"adjuvant chemotherapy":1,
"echinomycin":1,
"molecular targeted therapy":1,
"orthotopic mouse model":1,
"Gastric cancer":1,
"HLA-E":1,
"HLA-F":1,
"immuno suppression":1,
"postoperative outcome":1,
"Radiation-induced":1,
"re-irradiation":1,
"second malignancies":1,
"Clinical decision support systems":1,
"Decision aids":1,
"Lung cancer":2,
"genetic testing":1,
"Glioblastoma multiforme":1,
"multiple primary malignancies":1,
"Recurrence":2,
"Spinal neoplasms":1,
"cDNA arrays":1,
"metastasis":1,
"sirtuin-7":1,
"oncogenes":1,
"protein-protein interactions":1,
"signaling transduction":1,
"thyroid hormone":1,
"thyroid hormone receptors":1,
"CUDC-101":1,
"EGFR":1,
"HDAC":1,
"quantitative high-throughput screening":1,
"Langerhans cell histiocytosis":1,
"Lymphoma thyroid":1,
"Thyroid tumor":1,
"Thyromegaly":1,
"CT, computed tomography":1,
"MRI, magnetic resonance imaging":1,
"Sistrunk procedure":1,
"TDCC, thyroglossal duct cyst carcinoma":1,
"Tall cell carcinoma":1,
"US, ultrasonography":1,
"X-ray":1,
"computed tomography":1,
"Computers":1,
"Software":1,
"TBL1X":1,
"TBL1XR1":1,
"coactivator":1,
"corepressor":1,
"CD56":1,
"E-cadherin":1,
"HBME-1":1,
"follicular-patterned lesions":1,
"galectin-3":2,
"thyroid papillary cancer":1,
"Autonomously functioning thyroid nodule":1,
"Marine-Lenhart syndrome":1,
"papillary microcarcinoma":1,
"thyroid scintigraphy":1,
"toxic nodular goitre":1,
"BRAFV600E":1,
"PAX8-PPARγ":1,
"RET/PTC1":1,
"Immunocytochemistry":1,
"trucut biopsy":1,
"CTNNB1":1,
"TP16":1,
"adrenal cortical adenoma":1,
"adrenal cortical carcinoma":1,
"adrenocortical":1,
"beta-catenin":1,
"point mutation":1,
"serum biomarkers":1,
"Magnetic resonance imaging":1,
"PHACE":1,
"Vascular anomalies":1,
"APE1":1,
"Epithelial-Mesenchymal Transition (EMT)":1,
"non-small cell lung cancer (NSCLC)":1,
"Hepatocellular carcinoma":2,
"In situ tissue analysis":1,
"Invasive ductal carcinoma":1,
"Pancreatic ductal carcinoma":1,
"Prostate cancer":1,
"Zinc":1,
"Zinc cytotoxicity and carcinogenesis":1,
"c-MET":1,
"clinical trials":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2015年4月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO4AAADICAYAAADvG90JAAAWNElEQVR4Xu2dedS/5ZzHX/6YmVJRKi1ojwqjydaqIilJacgkhFSYM5UkSyiFSpaypIXRiJBjyJqTZBjLjL2hxZpMRqEkSxznzJz3dH1PT0/P83zv5bqv5b7fn3O+5+l3uu/r8/m8r/t9L9f1We6GxQgYgeoQuFt1FttgI2AEMHF9ERiBChEwcSucNJtsBExcXwNGoEIETNwKJ80mGwET19dAbAS2BDYNv/sA9wLWAtYEVpuj7M/Ab8LvZuB64Mrw+3lsQ2sez8Stefby2r4TsBtw/wVEve+AJv0C+BxwOfAZ4GcD6ip+aBO3+CkqxsB1gKcBewK7Aqtntuwa4JPA24CfZLYluXoTNznkVSlcA/h74OnAYwq2/ELgNcBVBdsY1TQTNyqcoxnsAcAxgbB3r8grvUafCVxckc2dTDVxO8E22pM2CRf+Eyv38EvAUcA3KvdjWfNN3LHObHu/TgJe2f60os/Q6/PYfPp/wE3coq+7JMZtD7wf0NN2jPKFsKimraXSZGNgL+BfgNvaGGfitkFrfMe+FDhlfG7dxaNbgBcAWsTKLdrXfirwDGAH4BHA19oaZeK2RWwcx2vB6WOFrxQPgfR5wOFDDDxnTAWePBn4h/CEnR1+EPCBLvYMQdytp7Qs3wX0As5RIMPuBdiRw4QvA/uE6Kyh9e8NHBy21FZZpExrCid0NWAI4upOrjvM/sCtXQ3zeYMhoK2S2leN+4KjMMpdgJv6DrTE+YooU6CKnqYK9VxKPgQc2Ed3bOJuGOJLZdN3wmuBQtUsZSBwLnBYGaZkt+KK8NYRg7wK+3xm+G7daI5nXwce3tf72MQ9GnjzAqO0krcHcHVfQ31+bwQOAD7ce5RxDaCHi67PX3Vwa/0QoKJX4W0bnq/46ocCv2x4/LKHxSbuUt9OyvJ4PPDVvsb6/M4IKPj/v0KGTudBRnqiyKstsSbbMfcMC0xaFW67RqDxHwnoSd9bYhJ3XeDGZSz6Y3BY37+W9AhcBjw6vdpqNCrS6uSQdbSU0SLpc8O3a1en9gU+0fXkxefFJO6hwDvnGPY84JxYxnucRggcApzf6EgfpLfD2RPxr4ENIgWmHAu8MSa8MYnbdLXydcDxMZ3wWMsisCrwY0DfY5Y8CLwbeE5s1TGJ+78tjNNyuFbhmnxXtBjWhy5C4MQ+e4VGszcCegXfufcoSwwQi7jK1fxsSwMV5qX3/htanufDmyGwXkgw11PXkh4BJfdrBVmv39ElFnFPB/Qe31ZUR+hxwHfbnujj5yLwcuC1c4/yAUMg8NuwV/v9IQbXmLGIq62GB3U08vdhtc4rzh0BXOY0VYPYKu6QHq0hAtob1kr+YBKDuMp2+HUEC18GnBphHA9x+yuaInQs6RFQZNq83ZXeVsUgruJeY5UK6R3D2RuRcQxwRqgAMQ5v6vFCuL8whbkxiHsacFxEYxVhtd8KwRwRVY12KMWHa3HKkg6BSwBlAyWRGMRVhQFlWsQUXXgi73/GHHQiYz3Qi33JZ1rZRgpn/F0qzTGIq8WloSoBvgh4UyowRqLn+cBZI/GlBjeUoPAw4Kc9jd0GUHVNBcwofnpF6UtcKRo680erzcpv1A3CMh8BVVRQELwlDQJtSs8oSUG7L1rtF3dmf5UWKGm8xtOXuE8BLkqAj6rWKzF/6JtEAlcGV/E/DnEcHOOZAj1QVGhvsYiIWwSSiqD6t56o2oFZTrQS3ThXui9xXwW8OhFMeuIq5jPFjSKRS9HVbA78MPqoHnApBPQJp/xmkVK/Bweydtk7f0vbXYC+xNXdRgWwUkprJ1Mal1mXFvQ+mtkGq2+HgGIXFMPQSvoSV5Xit2ulMc7B3wrfcT+IM9xoRlHbkKjpY6NBpkxHVKxdRdtbS1/iql7tPVprjXOCkvO16vyOOMONYhStJmtV2VI+AgrUUMBGJ+lDXK2QqQlxblGrRSWLxwi7zO1LX/3qG6s2mJayEdDN9ew+JvYhrlbNSnlVVckcrfANGtjdB+hE5/4I2CyRLqvphoBalr6v26l3nNWHuIoUKa0AnJoc/1NfUCo+v00xg4rdrNZ07a9H2RXpQ9xHAf9WIIR6C1B1jdJuKimgMnFToNxNhyqdfrrbqXc9qw9x1bBI7RxKFRWle/GEuilokVCLhZbyEIien9uHuKrGXnoSgJIVjggNrsqbzrgW3dtlgOICGmE01VRTxtDnI4x1pyH6EPdvmwRDxza443iKcFGbxeXqPncctqjT7gdcV5RF0zZG5WtUlmmQT7Y+xFVol8qj1CICUnnDY63rXNIqfy3XxFB26pNFBei/OZSCPsRVrV4FtNcmAlPB3IOBmgkQ5+FmAn6RWsUTaOFWObqDSR/iyqiaVzHVue4lhQSRxJjgmj5dYvhb4hh6kKldibLZBpW+xFXy8Ly2goM60HNwtVhUGdMxvD4rz1PVNi15EFAnvl1DLevBLehLXIUban+qdtHq+FFDLSQkAidFUYNErlSnRrEDetKqrWwS6Utc9QFqnZKUxLNuSnQjUsaGso9qk01S3e1rA2Zge/UtK9Im3bHoS1xtLF86MDA5hv/XQOBBFxgiO7ZSm9PIqjxcQODbgNrvxOhq3wrUvsRVX5o/tNJY18EXhgofg7WSiAjH6hOKEosIW+ehRNZNAW0zJpe+xJXBCppW7akxi4p4nVLBK3TNq/y1XT9ajMq2MBuDuDsCaic4Bbk8lIuN1lk8MmgmbmRAVxhOZVn1eZJFYhBXhmvfalZiMosjiZWqu+CZgEqhJiuC3cBH2bJag+N8SH8EVLxQnydZJBZxp1qEW9/3Ks72HkDVJ3LLL4F1chsxIf2x+NMasliKVwGunXi/GpFGBP4goKbdOURJBko2sKRBIBZ/WlsbU7Gyb97e2oJxnqCbmMqT6FU6ZdNurX5vOU5Ii/RKrXdUtDC5xCSujFffEy2RW+5AQHvBWpX+SII0yCtCYW7jnwYBFS+4NY2qO2uJTVwVR1+qJUMO30rUqS4DIrD6If37AAb+B6BeNpY0CKyZq+pIbOIKLnVCV0d0y3wEVLNLW2lfDNVE+kbgaDyllFnSILB2jqgpuTYEcUus/phmGvtr0aa+4qT10z6hcju16KW/ioVdKYhdscp6JVfLR0saBNQ8PGmM8sytIYirsY/v2lohDd7WYgSiIKA6X7qxJpehiCtHvgJsn9wjKzQC6RBQ28yb06m7Q9OQxNV+orZCcvUWyoGndU4LAbXhqTbJYKWp2gcoNa53WpeYvR0CAYWXZsmOG/KJOwNKja/VANtiBMaGQAr+LIlZKsVKTH/S2GbN/kwegVT8uQvQXRQfCagrfFvRXuXObU/y8UagUASUibVGLtvaEndWZUElO5Q8r0igpiInFTG0W9MTfJwRKBiBGwDVFs8ibYm7MGle+YhHA+9sablCIhUaaTECNSOgXsTqHpFF2hL3ucB5iyxVaVPl47bpDHAicEIWj63UCMRB4DvAtnGGaj9KW+KeFvrvLKXpvaEuU9PKiAcAFwBKjbIYgdoQUJLILrmMbktckfPgOcZ+FjgbUIe8eaLcUWXLqO+NxQjUhIDWa/bLZXBb4l4SWgc2sVcf76oIIWIq/HE50RP3WOAYQJEoFiNQAwL/DByay9C2xNX3rBpatxU1Q7osEFhlXX4Ssl80jkIj1bBKokZcG7Yd3McbgQwIvD40jcugun1an5pKqbmUxQhMHQH1Wj49Fwhtn7haeNo6l7HWawQKQuA5wLtz2dOWuAq8eEguY63XCBSEwN6A1nyySFviuqZRlmmy0gIR0LpMtn7EbYmrrR51J7MYgakjkC2JXsC3Ja6KfR849Rmz/0agA3eigtaWuCp4rsLnFiMwZQTUgT5rr6y2xFWgRLYl8ClfKfa9KAT0yfjYnBa1Je4TgI/nNNi6jUABCCikV4k12aQtcVW7V1FPFiMwZQT05vnGnAC0Ja5sVQyy6slajMBUEdgfuDin812IK4OfmNNo6zYCmRFQ2O/3ctrQhbhHAWfkNNq6jUBmBFYFbstpQxfiqo2m2mlajMAUEbgG2Cq3412IK5tVtmOWipfbB+s3AikRUGO17EFIXYmrInFvTomWdRmBQhB4ZQkN7boSV5UqflMIkDbDCKREIPuKspztSlyd+y5AOYkWIzAlBDYGrsvtcB/ibgaotqzFCEwFATUbX7cEZ/sQV/afAxxegiO2wQgkQEDhvkXEMPQl7gaAMiXUbtBiBMaOQBELU32/cWeTpDQ/pftZjMDYEdgTuLQEJ/s+cWc+fBnYoQSHbIMRGBCBbB3oF/sUi7haafsuoG5+FiMwRgS+BWxXimOxiCt/9g1tNEvxzXYYgZgIKOBI3TaKkJjElUOvBV5ehGc2wgjEReBJwEfjDtl9tNjElSVn5a4O0B0On2kElkVgbeCmUvAZgrjy7UzgyFKctB1GoCcCRX3fypehiKux9cqsV2eLEagdgZOBV5XkxJDElZ+7AkqDKiJMrCTgbUtVCDwSUKfKYmRo4srR9UPn+T2K8dqGGIHmCBQTn7zQ5BTEnelTE2BVxnPz6uYXjY/Mj4A68hWXBZeSuJoCNa3WqvN++efDFhiBRggoqaC4WuKpiTtDavtQRcANxBpdOz4oEwK3AvfIpHtFtbmIOzNqF+DVwO4lgmObJo/Ae4BDSkQhN3FnmGwR8nqf5RXoEi+TydqkMN5PlOh9KcRdiM1BIe55N0D5vhYjkAOBW4A1cyhuorNE4i60W60MtRcsEu8MbNTEKR9jBCIgcC5wRIRxBhmidOIudlo9i3YMub9a4HoYcPdBkPGgU0dgJ0B55kVKbcRdCKIIrJhokddiBGIioCKIWncpVmojrkInDwAOBrQibTECQyBQTG2p5ZzLQdxtgFeE0q7XAj8F/rKMgSKqgjY2D9+6bnsyxGXqMRcjUETt5JWmJQdxtVJ3s68VI1AoAh8Jb3WFmne7WTmIK71fBZRxYTECpSGgXYwvlGbUYntyEfc44LTSwbF9k0PgKkCfcsVLLuK6x27xl8YkDXw2cH4NnucirrD5YgiqqAEn2zh+BIrMu10O9pzEPQxQdIrFCJSAwLEhX7wEW+bakJO4qwLXA2vNtdIHGIFhEVCv5/sBvxtWTbzRcxJXXiilr6giXPGg9UgVIXAScEJF9mbbDpphtE4IwHC8cU1Xzbhs/UNIXvl1TW7lfuIKK4WX6Y5nMQI5ENAbn8qvViUlEFe9dRXUvV5VyNnYMSBwI7AZ8PvanCmBuMJMxeOK6ctS2yTa3s4IPA84p/PZGU8shbiC4EJA1S8sRiAFAlcDW6dQNISOkoir5IMrXa5miGn2mEsgsBfwmVqRKYm4wnDbUHVAe7wWIzAUAh+rvbZ3acTVRKkA9cVDzZjHNQJh++dnNSNRInGF50uAU2sG1rYXi4A6SKqQQ9VSKnEF6hnAUVWja+NLQ0Dbjg8CbivNsLb2lExc+aKGSyqSbjECMRB4BPC1GAPlHqN04gqfC4Cn5wbK+qtH4A3Ai6v3IjhQA3Fl6vGhSdhYcLcfaREovtxqWzhqIa78UnSVgjSckNB2ln383wHfHhMMNRFXuD8YuAjYakyTYF8GRaCqBPmmSNRG3Jlf6mBwZFMnfdxkEbgM2GOM3tdKXM2FmmLr1Vn9hCxGYDECqiGlWGT9HZ3UTFxNhrqFK59Xr0MWI7AQgSrqI3edstqJO/Nb9YJOB57aFQifNyoEqkyObzMDYyHuzGd17jsR2KcNCD52VAhcCuw5Ko+WcGZsxJ25+ADgaOCZ3j4a+yV8J/9+HjoRqJv8qGWsxJ1Nmkq/Hgqo0oE6/lnGi4Aaye0ccrrH62XwbOzEXTiBegrvG36PGv3MTstBVWrcbSxxyE2mbkrEXYjHPYH9Q8/dHRzQ0eRSKfqYRwOXF21hZOOmStzFMIrIOwHbAzuGFqCrR8baww2DgAovfHyYocsd1cRdem5eP6ZMknIvv96WPQN4b+9RKhzAxL3rpGkrodoiYhVeg11N/kfgrK4n136eiXvnGdwF+DSgIu2WchHQXr36Tk1WTNw7pl6rkiLtKpO9GupwXBFyx9Vh6nBWmri3Y/sC4O3DweyRIyGguPTXRBqr6mGmTlzt7X4QeEjVszgN4xUJp3ROC2Rvs5lzEp4citF52yfnLDTTfThwXrNDp3HUFJ+42qt9HbD7NKa4ai/VRU832Euq9mIA46dEXNWs0uuWFqEs5SPw38DjphJ73HY6xk7c+wDPDokGm7QFx8dnQ+ArIaa8qi7xKdEaK3EVUSPC+nU45dUUR5eCKhRcYVkBgTERVxUglTjwfLfqrPaa1832/GqtT2h4zcRVfWUVjHtseK3yq3DCCyeyquvDTffrkccd7XC1EVcFwPT6qzQuhSda6kfgU8AhY63GONT0lEpcVW/cBrg/oCAJJb6ruoFlPAj8ETgGOHs8LqXzpATibgpsBqiTmoq96e9900FgTRkQUMe8gwD19LF0QCAFcbcIRBRBNw6/jQJZ/V3aYdIqP0VNpdVc2tIDgT7EVdWIDcMKruoaa89UPz0t1wdE1HV72OZTx4XAN8K37PfG5VYeb1Yirkj4ImANQPG8+qtvzxlZ3TUvz5zVqPVlwKk1Gl6qzfOeuNoXVVf4NUt1wHYVjcDnQjDF1UVbWaFx84grl9YJmRkiscUINEHgupDsrpRJywAINCHuTO2zgLeG1+YBTPGQI0BA9Y1PcbL78DPZhriyRqvCenV2DPDwc1OThtuAc8Nq8Y01GV6rrW2JO/NTkS5vAu5Vq+O2OxoCCqA4GVDfHksiBLoSV+ZphfmlwAtdYC3RbJWl5m1hpVhxxpbECPQh7szU9YCTAJUXsYwbAb0SK+1OBeNvGLerZXsXg7gzDxVwoYgYhbJZxoXAb0MVzDcAN43LtTq9iUncGQJKDlDB6qfUCYmtXoDAr4Azwm6CyGspBIEhiDtzTYkD+gY+rBBfbUZzBBT8r6erM3eaY5b0yCGJO3NE8coKnVTRcYVNWspF4DLgXcD7yzXRlgmBFMSdIa14Z3WG1yq04p0tZSDwTeB9oeud92DLmJO5VqQk7kJjjgCODMnyc430AdER+CHwAeAC4PvRR/eAgyOQi7gzx5Q4r1BKrUQ7mGPY6Vb88EWBsEqxs1SMQG7iLoTuwJCv+fiK8SzN9F8EsoqwXyrNONvTHYGSiDvzQnm+qmC/L7APcO/u7k3yTO2zfjg8WZVWZxkhAiUSdzHMOwQC7w1sN8I5iOGSvlkvBy4GPhljQI9RNgI1EHchgmsDe4Un8p6Awi2nKD8APr/g5wD/iV0FtRF38fQ8FNgJ0FNZP6UdjlFmT9QZWU3UMc5yC59qJ+5iV/U9LCLvCDw81GXeoAUeuQ/Vk/Qq4BpA5V709wrg1tyGWX9ZCIyNuEuhuyqwJaAysZuHvwrHVDVKkVrVKlOJYn/VPlI/pcNdG/ZRRdIrUxlhPfUjMAXizpulVUJZWZFYP0V1rQWsFvKM/yb81XGz318Bfwo/pbrN/lt/Z/++ZRFJXfx73kz4/zdGwMRtDJUPNALlIGDiljMXtsQINEbAxG0MlQ80AuUgYOKWMxe2xAg0RsDEbQyVDzQC5SBg4pYzF7bECDRG4P8A3SKu5/rwGYoAAAAASUVORK5CYII=';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
